Toxicity of pyroglutaminated amyloid β-peptides 3(pE)-40 and-42 is similar to that of Aβ1-40 and-42

被引:45
作者
Tekirian, TL
Yang, AY
Glabe, C
Geddes, JW
机构
[1] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[3] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA
关键词
Alzheimer's disease; amyloid beta-peptide; circular dichroism; neurotoxins; peptide fragments;
D O I
10.1046/j.1471-4159.1999.0731584.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An N-terminal truncated isoform of the amyloid beta-peptide (A beta) that begins with a pyroglutamate (pE) residue at position 3 [A beta 3(pE)-42] is the predominant isoform found in senile plaques. Based upon previous in vitro studies regarding A beta N-terminal truncated isoforms, it has been hypothesized that A beta S(pE)-x isoforms may aggregate more rapidly and become more toxic than corresponding A beta 1-x peptides, However, the toxicity and aggregation properties of A beta 3(pE)-42 and A beta 3(pE)-40 have not previously been examined. After initial solubilization and 1-week preaggregation of each peptide at 37 degrees C and pH 7.4, the toxicity of 5-50 mu M A beta 3(pE)-42 was similar to that of A beta 1-42. Moreover, the toxicity of A beta 3(pE)-40 paralleled that induced by A beta 1-40 in both 1 day in vitro (DIV) cortical and 7 DIV hippocampal cells. Circular dichroism spectra did not reveal major differences in secondary structure between aged A beta 1-42, A beta 3(pE)-42, A beta 3(pE)-40, and A beta 1-40 or freshly solubilized forms of these peptides. Overall, the data indicate that the loss of the two N-terminal amino acids and the cyclization of glutamate at position 3 do not alter the extracellular toxicity of A beta.
引用
收藏
页码:1584 / 1589
页数:6
相关论文
共 22 条
[1]  
[Anonymous], 1986, MAMMALIAN PROTEASES
[2]   OPTIMIZED SURVIVAL OF HIPPOCAMPAL-NEURONS IN B27-SUPPLEMENTED NEUROBASAL(TM), A NEW SERUM-FREE MEDIUM COMBINATION [J].
BREWER, GJ ;
TORRICELLI, JR ;
EVEGE, EK ;
PRICE, PJ .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 35 (05) :567-576
[3]  
BURDICK D, 1992, J BIOL CHEM, V267, P546
[4]  
CHECLER F, 1995, J NEUROCHEM, V65, P1431
[5]   DIRECT EVIDENCE OF OXIDATIVE INJURY PRODUCED BY THE ALZHEIMERS BETA-AMYLOID PEPTIDE (1-40) IN CULTURED HIPPOCAMPAL-NEURONS [J].
HARRIS, ME ;
HENSLEY, K ;
BUTTERFIELD, DA ;
LEEDLE, RA ;
CARNEY, JM .
EXPERIMENTAL NEUROLOGY, 1995, 131 (02) :193-202
[6]   AGGREGATION STATE AND NEUROTOXIC PROPERTIES OF ALZHEIMER BETA-AMYLOID PEPTIDE [J].
HOWLETT, DR ;
JENNINGS, KH ;
LEE, DC ;
CLARK, MSG ;
BROWN, F ;
WETZEL, R ;
WOOD, SJ ;
CAMILLERI, P ;
ROBERTS, GW .
NEURODEGENERATION, 1995, 4 (01) :23-32
[7]  
JIANG HX, 1994, J IMMUNOL, V152, P5050
[8]   Cerebral vessels in ageing and Alzheimer's disease [J].
Kalaria, RN .
PHARMACOLOGY & THERAPEUTICS, 1996, 72 (03) :193-214
[9]   Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease [J].
Kuda, T ;
Shoji, M ;
Arai, H ;
Kawashima, S ;
Saido, TC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (03) :526-530
[10]   Regulation of amyloid precursor protein cleavage [J].
Mills, J ;
Reiner, PB .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :443-460